Neuropace Inc expected to post a loss of 53 cents a share - Earnings Preview

NeuroPace

05/11/2022 03:24

* Neuropace Inc  NPCE.OQ   NPCE.O  is expected to show a
fall in
quarterly revenue when it reports  results on November 8. 
    * The Mountain View California-based  company is expected to
report  a 4.3% decrease in revenue to $9.891 million from $10.34
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Neuropace Inc is
for a
loss of 53 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Neuropace
Inc is
$6​, above​ its last closing price of $2.34. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.44       -0.44      -0.52     Missed  -17.3
 Mar. 31 2022  -0.45       -0.44      -0.47     Missed  -6.2
 Dec. 31 2021  -0.32       -0.33      -0.44     Missed  -33.3​
 Sep. 30 2021  -0.31       -0.30      -0.34     Missed  -11.8
 ​​Jun.        -0.34       -0.34      -0.48     Missed  -42.6
 30 2021                                                
 Mar. 31 2021  -0.28       -0.28      -32.73    Missed  -11,58
                                                        9.3​
 This summary was machine generated November 5 at 03:24 GMT.  All
figures in US dollars  unless otherwise stated